These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31761136)

  • 21. Growth-promoting effect of recombinant human growth hormone and stanozolol in girls with Turner syndrome.
    Fang J; Ning C; Shu D; Wei H; Lin H; Wang M
    J Tongji Med Univ; 1999; 19(1):63-5. PubMed ID: 12840880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hormone-induced and chondrodystrophic growth disorders].
    Góth E
    Orv Hetil; 1970 May; 111(18):1039-45. PubMed ID: 5454003
    [No Abstract]   [Full Text] [Related]  

  • 23. [The Ullrich-Turner syndrome].
    Butenandt O
    Fortschr Med; 1980 Jul; 98(25):958-62. PubMed ID: 7450634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone therapy in Turner syndrome. Analysis of long-term results.
    Ranke MB
    Horm Res; 1995; 44 Suppl 3():35-41. PubMed ID: 8719439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience in management of diminished growth in adolescent Turner's syndrome patients.
    Tuschy U
    Padiatr Grenzgeb; 1992; 31(2):123-30. PubMed ID: 1305284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone therapy in Turner syndrome.
    Davenport ML
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():723-4. PubMed ID: 22946284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifracture efficacy of long-term estrogens for osteoporosis.
    Gordan GS; Picchi J; Roof BS
    Trans Assoc Am Physicians; 1973; 86():326-32. PubMed ID: 4363387
    [No Abstract]   [Full Text] [Related]  

  • 28. [The clinical use of anabolic steroids].
    Bierich JR
    Monatsschr Kinderheilkd (1902); 1966 Aug; 114(8):444-54. PubMed ID: 5991491
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of estrogens on gonadotropins and growth hormone secretion in Turner's syndrome and pure gonadal dysgenesis.
    Zarzycki J; Pawlikowska-Haddal A; Hilczer M; Nalewajek H
    Endokrynol Pol; 1989; 40(5):235-9. PubMed ID: 2641512
    [No Abstract]   [Full Text] [Related]  

  • 31. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure and Turner syndrome.
    Nathwani NC; Unwin R; Brook CG; Hindmarsh PC
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):363-70. PubMed ID: 10718835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of digitoxin poisoning by various steroids.
    Selye H; Jelinek J; Krajny M
    J Pharm Sci; 1969 Sep; 58(9):1055-9. PubMed ID: 5346064
    [No Abstract]   [Full Text] [Related]  

  • 34. [Optimizing estrogen treatment in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 2003 Mar; 144(12):563-8. PubMed ID: 12723527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gonadal dysgenesis].
    Jancu J; Pertzelan A; Laron Z
    Harefuah; 1974 Jan; 86(2):77-80. PubMed ID: 4826061
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anabolic steroids and growth].
    Bierich JR
    Munch Med Wochenschr; 1971 Jun; 113(25):942-8. PubMed ID: 4996666
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anabolic steroids and growth].
    Bierich JR
    Minerva Med; 1971 Jun; 62(51):2572-9. PubMed ID: 5566870
    [No Abstract]   [Full Text] [Related]  

  • 38. Gonadotrophin pulsatility in girls with the Turner syndrome: modulation by exogenous sex steroids.
    Nathwani NC; Hindmarsh PC; Massarano AA; Brook CG
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):107-13. PubMed ID: 9797854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term treatment of gonadal dysgenesis].
    Schmid-Tannwald I; Hauser GA
    Gynakol Rundsch; 1973; 13():Suppl 1:69-76. PubMed ID: 4798938
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of anabolic steroids. VI. Effect of prolonged administration of oxandrolone on growth in children and adolescents with gonadal dysgenesis.
    Moore DC; Tattoni DS; Ruvalcaba RH; Limbeck GA; Kelley VC
    J Pediatr; 1977 Mar; 90(3):462-6. PubMed ID: 190369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.